Brief: Halozyme Announces Global Collaboration And License Agreement With Vertex Pharmaceuticals For Hypercon™ Technology
07/04/2026 13:06
April 7 (Reuters) - Halozyme Therapeutics Inc HALO.O: HALOZYME ANNOUNCES GLOBAL COLLABORATION AND LICENSE AGREEMENT WITH VERTEX PHARMACEUTICALS FOR HYPERCON™ TECHNOLOGY HALOZYME THERAPEUTICS INC - VERTEX TO MAKE $15 MILLION UPFRONT PAYMENT TO HALOZYME HALOZYME THERAPEUTICS INC - VERTEX LICENSES HALOZYME'S HYPERCON TECHNOLOGY FOR UP TO THREE DRUG TARGETS Source text: ID:nPnFqDPZa Further company coverage: HALO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Halozyme Therapeutics
See all newsUS RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Halozyme wins court order to block Merck's injected Keytruda in select European markets (updated)
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
Halozyme wins court order to block Merck's injected Keytruda in select European markets